April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
Teladoc Health (TDOC) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: May 16, 2025 (02:35)
Sector: HealthcareThe share price of Teladoc Health, Inc. (TDOC) now
News Impact Analyzer
Full report
This Week
|
Na | Impact: Na | News: Na |
Previous Week
|
Na | Impact: Na | News: Na |
Two Weeks Ago
|
Bullish | Impact: 5 | News: 3 (2/1/0) |
Three Weeks Ago
|
Bearish | Impact: 5 | News: 1 |
Analysts predictions
Full report
This Week
|
Neutral | Opinions: Na |
Previous Week
|
Neutral | Opinions: Na |
Two Weeks Ago
|
Bearish | Opinions: 1 |
Three Weeks Ago
|
Neutral | Opinions: Na |
Analyzing the Most Important TDOC news

Teladoc Health Exceeds Q1 2025 Targets with Integrated Care & BetterHelp Successes


Teladoc Health Reports Surge in Integrated Care Members for Q1


Teladoc Health Acquires UpLift to Expand Virtual Mental Health Services

Historical and forecast chart of Teladoc Health stock
The chart below shows the historical price of Teladoc Health stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Teladoc Health stock price can be found in the table below.
Long-term forecasts by years.
Teladoc Health, Inc. Analysts predictions review

Teladoc Health is currently facing significant challenges that may depress its stock performance in the near term. Key issues include stagnating revenue growth, elevated operating expenses, and a lack of profitability, compounded by increasing competition in the telehealth sector. Market saturation and weakening user adoption further erode its competitive edge, while management’s downgraded guidance underscores structural and operational inefficiencies. Additionally, the absence of clear growth catalysts or innovation initiatives limits the likelihood of near-term recovery, and macroeconomic pressures like inflation exacerbate demand risks. These factors collectively signal a challenging outlook for the company.

Teladoc Health: Mounting Challenges and Limited Upside

Teladoc Health faces several headwinds that could constrain its stock performance in the near term. Revenue growth remains stagnant, reflecting challenges in scaling new service offerings and maintaining demand in a competitive virtual healthcare landscape. Despite temporary cost-cutting efforts, profitability remains distant due to elevated operating expenses, casting doubt on the company’s ability to drive sustainable earnings growth.
Key Risks and Market Dynamics
Competition from large, well-resourced players in the telehealth market adds significant pressure on Teladoc. This dynamic could erode its market share and lead to lower pricing power and margins. Additionally, the lack of clear innovation initiatives raises concerns about strategic differentiation, reducing its appeal to institutional investors seeking growth-oriented opportunities.
The author also emphasizes the absence of catalysts on the horizon to reverse ongoing sentiment. With a declining trajectory in investor confidence and limited avenues for immediate operational improvement, the stock may struggle to generate meaningful upward momentum in the near term.

Teladoc Health: Assessing Risks After Persistent Challenges

Teladoc Health faces ongoing challenges related to profitability concerns, indicating that its path to sustained earnings growth may be longer than initially anticipated. The company's elevated operating costs and constrained profitability metrics have raised doubts about its capacity to achieve meaningful financial improvement in the near term, posing a risk for investors.
Heightened Competition and Growth Deceleration
The emergence of fierce competition in the telemedicine space has exacerbated pressure on Teladoc's market share and pricing power. This intensifies the difficulties of maintaining robust revenue growth as consumers now have abundant alternatives in digital health services.
Moreover, management's downgraded forward guidance signals a lack of near-term tailwinds, further dampening investor confidence. Weak projections may also reflect potential structural issues within the business model, which could continue to hinder operational scalability and shareholder returns.

Teladoc Faces Stagnant Growth and Uncertain Recovery: Key Risks for Investors

Teladoc’s limited growth opportunities, coupled with its mounting competition in the telehealth sector, pose significant risks to its financial performance. The author's assessment highlights that the company’s path to profitability remains unclear, which amplifies concerns over its stock’s ability to recover in the near term.
Operational Headwinds and Strategic Challenges
The company’s continued struggle with operational efficiency undermines its capacity to streamline costs and execute scalable solutions. Furthermore, the author's view on increased market saturation emphasizes that Teladoc's slowdown in user adoption could erode its competitive edge.
Macroeconomic factors exacerbate the company's challenges, as inflationary pressures and declining consumer spending hinder demand for discretionary services like virtual healthcare. The author’s observation about Teladoc's dependence on external factors like insurance partnerships reveals vulnerabilities in its business model that could weigh on its valuation.
Finally, skepticism surrounding the management’s ability to deliver on growth objectives, as outlined in the analysis, casts doubt on whether the company can rebuild investor confidence effectively. These factors collectively suggest sustained downward pressure on Teladoc's stock performance in the near term.
Teladoc Health's performance is heavily constrained by the lack of a clear growth catalyst, which has raised concerns about the company's ability to sustain its market position in the competitive telehealth sector. The absence of robust innovation or expansion strategies makes the stock vulnerable to investor skepticism and limits its appeal in the near term.
Revenue Growth, Profitability, and Competition
Despite steady revenue generation, Teladoc's profitability metrics remain under pressure, owing to high operational costs and pricing challenges within the virtual healthcare space. Investors are likely to focus on margin improvement as a critical driver for stock recovery.
Escalating competition from both established healthcare providers and new market entrants further undermines Teladoc's ability to maintain pricing power and customer retention. This intensifying rivalry could negatively impact growth prospects unless the company differentiates itself through unique offerings.
Finally, macroeconomic conditions, including rising interest rates and economic uncertainty, could weigh on the sector's valuation as a whole. Teladoc's highly leveraged balance sheet leaves it particularly exposed to these external risks, adding another layer of vulnerability to its stock performance.
The analysis centers on Teladoc Health's potential resurgence, driven by macroeconomic and competitive dynamics. One key factor highlighted is Teladoc's strategic alignment with Amazon, which could provide crucial support for expanding its virtual healthcare reach. This partnership leverages Amazon's vast customer base and distribution expertise, potentially enhancing Teladoc's topline growth and competitive positioning in a saturated telehealth market.
Market Forces and Strategic Adaptations
The author also underscores persistent challenges in Teladoc's core business model, particularly its struggles with profitability amidst heightened competition. Rising operating expenses and pricing pressures remain concerns that could dampen investor sentiment in the short term. Finally, Teladoc's ability to navigate these challenges through innovation, cost optimization, or further strategic partnerships will be a critical determinant of its near-term stock performance. While optimistic about potential recovery, the reliance on external forces points to a cautious outlook.
Teladoc Health is facing slowing growth as competition intensifies in the telehealth sector. The company is contending with mature market dynamics, where customer acquisition costs are rising, and competitive pricing pressure is eroding profitability.
Additionally, more healthcare players are diversifying or exiting the telehealth market, limiting Teladoc's ability to expand its total addressable market (TAM). This trend suggests that Teladoc has fewer opportunities for partnership or acquisition synergies in the near term, further constraining growth potential.
Expanding Weaknesses and Market Headwinds
Operational performance remains a concern, with inconsistent revenue growth and profitability metrics. If the company cannot demonstrate a clear path to sustainable margins, investor confidence is likely to wane, putting downward pressure on its stock price.
Macro-level challenges, such as regulatory scrutiny and tightening healthcare budgets, add an additional layer of uncertainty. These factors are likely to weigh on Teladoc's ability to innovate and differentiate its offerings, compounding its vulnerability to competitive pressures.
Teladoc Health's current valuation appears attractive, particularly in light of its position as a leader in the telehealth market. However, declining revenue growth and ongoing doubts about its ability to achieve profitability raise significant concerns about sustaining investor confidence. While the stock's discounted price suggests potential long-term upside, the lack of immediate financial clarity can weigh on near-term performance.
Key Challenges Undermining Growth Momentum
Macroeconomic headwinds, including inflation and rising interest rates, exacerbate Teladoc's financial difficulties by increasing operating costs and reducing consumer discretionary spending on telehealth services. These factors weaken forecasted cash flows, bringing downward pressure on the company's share price.
Additionally, competitive pressures in the telehealth space continue to mount, with new entrants and established players vying for market share. This intensifies pricing competition and threatens Teladoc's ability to expand margins, further complicating its growth narrative.
Lastly, management's strategic decisions and their execution will play a pivotal role in shaping the company's trajectory. Investors may remain cautious without clear milestones on cost reduction and tangible profitability improvements, limiting price movement in the short term.
Teladoc Health's key focus on expanding its primary care services creates a substantial opportunity for long-term growth, particularly as virtual healthcare adoption continues to rise. The author emphasizes that strategic partnerships and the broadening of service offerings align with Teladoc's aim to capture a larger share of the evolving telehealth market.
Macroeconomic pressures, including inflationary cost increases and reduced discretionary healthcare spending, pose challenges that could weigh on near-term revenue growth. However, the article highlights Teladoc's commitment to operational efficiency, which may partially offset these headwinds and signal improving margins over time.
Potential for Profitability and Valuation Concerns
The pathway to profitability remains a significant focal point, with the author suggesting that Teladoc is nearing a critical inflection point. If execution on cost control and user growth trajectories materialize as planned, this could act as a catalyst for positive sentiment and stock re-rating in the medium term.
Finally, valuation concerns remain a mixed consideration for investors. While Teladoc trades at a sizable discount relative to prior peaks, skepticism regarding its ability to achieve sustained profitability continues to shape investor sentiment, limiting immediate upside potential.
Teladoc Health's forecasted improvement appears driven by a key strategic focus on cost optimization and efficiency gains, as the company seeks to address lingering profit-margin constraints. The author highlights management's commitment to controlling expenses as a critical lever to navigate the competitive telehealth landscape, which is pivotal in sustaining investor confidence.
Patient Volume and Service Diversification As Catalysts
The ongoing diversification of Teladoc's service offerings, particularly in chronic care and mental health, is poised to boost patient engagement and subscription-based revenue. According to the article, these high-margin services position the company to mitigate risks associated with price competition in traditional telehealth segments.
Concerns persist over macroeconomic headwinds, including consumer spending pressure, which could temper near-term growth for TDOC. However, the author suggests that the overall shift in favor of virtual healthcare and Teladoc's expansive data-driven model should provide a longer-term tailwind for demand.
Finally, the valuation reset in Teladoc's stock—triggered by multiple quarters of underperformance—may now present an entry point for value-focused investors if execution on the aforementioned factors materializes. The author's upgrade reflects a cautious optimism but still acknowledges risks tied to broader market trends and operational delivery.
Comprehensive Analysis of Teladoc Health (TDOC) Stock Market Performance
Our multifaceted analysis of Teladoc Health's stock market is grounded in the company's key news stories, insights from reputable analysts, as well as mathematical and technical evaluations. Taking into account assessments from each of these aspects in real-time helps us address the most crucial questions for investors in the most objective way possible:
- When should I take profit in Teladoc Health stock?
- When should I record a loss on Teladoc Health stock?
- What are analysts' forecasts for Teladoc Health stock?
- What is the future of Teladoc Health stock?
We forecast Teladoc Health stock performance using neural networks based on historical data on Teladoc Health stocks.
Teladoc Health (TDOC) is a telemedicine software developer that connects patients with doctors through its platform for consulting and monitoring health indicators. With the help of video conferencing of the mobile application, remote medical care is provided to patients with cancer, heart failure and various chronic diseases. The company operates in 130 countries and has already served over 27 million people worldwide.
The company was founded in 2002. Capitalization – $ 22 billion.
Teladoc Health, Inc. News influencing stock rates

As of now, Panda has combed through 4 news items directly related to TDOC from the last 30 days. Out of these, 2 clearly showcase a bullish trend, while 1 display bearish tendencies, and 1 events are neutral.
The strength of the bullish trend outpaces the bearish sentiments by 2 times, indicating that the news backdrop is positively influencing the company’s stock price in the current outlook.
The news analyzed fell within the period from Apr 17, 2025, to Apr 30, 2025.
Major Downgrade Wave: AAPL, TDOC, and More Under Scrutiny


Teladoc Joins Eli Lilly's Weight-Loss Revolution with Zepbound Partnership


Teladoc Shares Slide Amid Disappointing Forward Outlook Despite Revenue Beat


Teladoc Health Q4: US Revenue Drops, International Growth Expands


Teladoc Tumbles 11% Post-Q4 Miss and Subdued 2025 Outlook


Teladoc Health Misses Q4 Earnings but Slightly Outpaces Revenue Expectations


Teladoc Health Q4 Earnings to Spotlight Acquisition Impact


Piper Sandler Highlights Value in Smaller-Cap Stocks Amid Market Volatility


Teladoc Health Expands Reach with $65M Catapult Health Acquisition


Stock Futures Rise Amid Tariff Strategy News


Teladoc Health daily forecast for a month
Date | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
May 17 | 7.24 | 7.14 | 7.39 | 3.45 |
May 18 | 7.29 | 7.19 | 7.39 | 2.68 |
May 19 | 7.12 | 6.94 | 7.33 | 5.65 |
May 20 | 6.89 | 6.67 | 7.00 | 4.96 |
May 21 | 7.23 | 7.05 | 7.35 | 4.31 |
May 22 | 7.10 | 6.99 | 7.22 | 3.30 |
May 23 | 7.28 | 7.11 | 7.54 | 5.94 |
May 24 | 7.46 | 7.27 | 7.74 | 6.47 |
May 25 | 7.46 | 7.37 | 7.62 | 3.34 |
May 26 | 7.14 | 6.89 | 7.38 | 7.04 |
May 27 | 6.96 | 6.87 | 7.21 | 4.96 |
May 28 | 7.09 | 6.93 | 7.29 | 5.16 |
May 29 | 7.05 | 6.85 | 7.13 | 4.06 |
May 30 | 7.38 | 7.18 | 7.57 | 5.50 |
May 31 | 7.29 | 7.11 | 7.41 | 4.21 |
Jun 01 | 7.14 | 6.91 | 7.32 | 5.94 |
Jun 02 | 7.03 | 6.83 | 7.11 | 4.01 |
Jun 03 | 7.14 | 7.04 | 7.31 | 3.80 |
Jun 04 | 7.21 | 6.98 | 7.44 | 6.67 |
Jun 05 | 7.14 | 7.06 | 7.26 | 2.73 |
Jun 06 | 6.97 | 6.74 | 7.17 | 6.41 |
Jun 07 | 6.66 | 6.49 | 6.78 | 4.47 |
Jun 08 | 6.77 | 6.55 | 6.87 | 4.85 |
Jun 09 | 6.80 | 6.61 | 6.92 | 4.79 |
Jun 10 | 6.65 | 6.45 | 6.83 | 5.93 |
Jun 11 | 6.63 | 6.37 | 6.77 | 6.30 |
Jun 12 | 6.47 | 6.33 | 6.69 | 5.78 |
Jun 13 | 6.27 | 6.21 | 6.50 | 4.65 |
Jun 14 | 6.32 | 6.20 | 6.57 | 6.02 |
Jun 15 | 6.25 | 6.15 | 6.33 | 2.95 |
Teladoc Health Daily Price Targets
Teladoc Health Stock Forecast 05-17-2025.
Forecast target price for 05-17-2025: $7.24.
Negative dynamics for Teladoc Health shares will prevail with possible volatility of 3.333%.
Pessimistic target level: 7.14
Optimistic target level: 7.39
Teladoc Health Stock Forecast 05-18-2025.
Forecast target price for 05-18-2025: $7.29.
Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.613%.
Pessimistic target level: 7.19
Optimistic target level: 7.39
Teladoc Health Stock Forecast 05-19-2025.
Forecast target price for 05-19-2025: $7.12.
Negative dynamics for Teladoc Health shares will prevail with possible volatility of 5.345%.
Pessimistic target level: 6.94
Optimistic target level: 7.33
Teladoc Health Stock Forecast 05-20-2025.
Forecast target price for 05-20-2025: $6.89.
Negative dynamics for Teladoc Health shares will prevail with possible volatility of 4.722%.
Pessimistic target level: 6.67
Optimistic target level: 7.00
Teladoc Health Stock Forecast 05-21-2025.
Forecast target price for 05-21-2025: $7.23.
Positive dynamics for Teladoc Health shares will prevail with possible volatility of 4.134%.
Pessimistic target level: 7.05
Optimistic target level: 7.35
Teladoc Health Stock Forecast 05-22-2025.
Forecast target price for 05-22-2025: $7.10.
Negative dynamics for Teladoc Health shares will prevail with possible volatility of 3.197%.
Pessimistic target level: 6.99
Optimistic target level: 7.22
TDOC (TDOC) Monthly Stock Prediction for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jun. | 8.17 | 7.89 | 8.78 | 10.05 |
Jul. | 7.86 | 7.43 | 8.24 | 9.80 |
Aug. | 7.64 | 7.26 | 8.39 | 13.49 |
Sep. | 7.37 | 6.91 | 7.71 | 10.43 |
Oct. | 7.11 | 6.79 | 7.40 | 8.25 |
Nov. | 6.66 | 6.36 | 7.01 | 9.26 |
Dec. | 6.74 | 6.25 | 6.98 | 10.41 |
Teladoc Health forecast for this year
Teladoc Health Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $8.17015. Pessimistic: $7.89. Optimistic: $8.78
Teladoc Health Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $7.86214. Pessimistic: $7.43. Optimistic: $8.24
Teladoc Health Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $7.63728. Pessimistic: $7.26. Optimistic: $8.39
Teladoc Health Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $7.36921. Pessimistic: $6.91. Optimistic: $7.71
Teladoc Health Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $7.11055. Pessimistic: $6.79. Optimistic: $7.40
Teladoc Health Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $6.65761. Pessimistic: $6.36. Optimistic: $7.01
Teladoc Health Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $6.73551. Pessimistic: $6.25. Optimistic: $6.98
Teladoc Health (TDOC) Monthly Stock Prediction for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 6.33 | 5.95 | 6.95 | 14.33 |
Feb | 6.69 | 6.11 | 7.06 | 13.44 |
Mar | 6.61 | 6.31 | 6.96 | 9.38 |
Apr | 6.63 | 6.40 | 7.19 | 11.01 |
May | 6.63 | 6.07 | 7.26 | 16.37 |
Jun | 6.58 | 6.30 | 6.89 | 8.57 |
Jul | 6.51 | 6.19 | 6.97 | 11.16 |
Aug | 7.33 | 6.79 | 7.93 | 14.42 |
Sep | 7.07 | 6.64 | 7.66 | 13.43 |
Oct | 6.81 | 6.54 | 7.00 | 6.58 |
Nov | 7.46 | 6.71 | 8.11 | 17.22 |
Dec | 7.28 | 6.59 | 7.75 | 15.01 |
Teladoc Health (TDOC) Monthly Stock Prediction for 2027
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 6.55 | 6.35 | 6.98 | 9.03 |
Feb | 6.38 | 5.97 | 6.61 | 9.67 |
Mar | 6.60 | 6.21 | 7.13 | 12.87 |
Apr | 6.03 | 5.48 | 6.51 | 15.90 |
May | 6.13 | 5.65 | 6.64 | 15.00 |
Jun | 6.09 | 5.56 | 6.51 | 14.59 |
Jul | 6.07 | 5.44 | 6.35 | 14.41 |
Aug | 6.81 | 6.52 | 7.02 | 7.07 |
Sep | 6.32 | 5.71 | 6.72 | 15.05 |
Oct | 5.68 | 5.18 | 5.87 | 11.81 |
Nov | 5.91 | 5.40 | 6.33 | 14.58 |
Dec | 6.26 | 5.72 | 6.73 | 14.99 |
Teladoc Health information and performance
2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE, NY, US
Market capitalization of the Teladoc Health, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of TDOC shares in the company outstanding by the market price of one share.
EBITDA of Teladoc Health is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Teladoc Health Stock)
Should I Buy Teladoc Health Shares in 2025 year?
Does Teladoc Health pay dividends?
Which economic sector do Teladoc Health's shares belong to?
Which other securities belong to the same sector as Teladoc Health's shares?
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.